Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
循环免疫细胞和结果分析:基于度伐利尤单抗阻断PD-L1治疗新诊断和复发性胶质母细胞瘤的II期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-4064
Nayak, Lakshmi; Standifer, Nathan; Dietrich, Jorg; Clarke, Jennifer L; Dunn, Gavin P; Lim, Michael; Cloughesy, Timothy; Gan, Hui K; Flagg, Elizabeth; George, Elizabeth; Gaffey, Sarah; Hayden, Julia; Holcroft, Christina; Wen, Patrick Y; Macri, Mary; Park, Andrew J; Ricciardi, Toni; Ryan, Aileen; Schwarzenberger, Paul; Venhaus, Ralph; Reyes, Melissa de Los; Durham, Nicholas M; Creasy, Todd; Huang, Raymond Y; Kaley, Thomas; Reardon, David A